Insmed | INSM - Despesas Operacionais

Preço das Ações
135.17
Mudança Diária
-8.66 -6.02%
Mensal
-8.86%
Anual
93.96%
Q2 Previsão
132.28




Despesas Operacionais Alterar Data
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
DBV Technologies USD 37.05M 4.06M 2025-09
Gilead Sciences USD 4.96B 707M 2025-12
Heron Therapeutics USD 40.55M 1.46M 2025-12
Insmed USD 513.55M 109.86M 2025-12
Novartis USD 9.8B 23M 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12